iVEAcare, a Roseville, MN-based development stage medical device company, raised $27.5M in Series A funding. Led by newly appointed President and CEO Todd Kerkow, and co-founder & Chairman Mudit Jain, iVEAcare is developing an innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations. It is focused on developing and commercializing technology platforms to treat patients suffering from chronic diseases.